Article
Integrated genomics of susceptibility to alkylator-induced leukemia in mice.
BMC genomics - 17 Nov 2010
Cahan Patrick, Graubert Timothy A
Abstract excerpt
BACKGROUND: Therapy-related acute myeloid leukemia (t-AML) is a secondary, generally incurable, malignancy attributable to chemotherapy exposure. Although there is a genetic component to t-AML susceptibility in mice, the relevant loci and the mechanism(s) by which they contribute to t-AML are largely unknown. An improved understanding of susceptibility factors and the biological processes in which they act may...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
